By

Kshithija KJ Mulam

2
Jun
2020

Puretech Focuses on the Long-Term Lung Complications in COVID-19 Survivors

All eyes are on the healthcare industry as biotech and pharmaceutical companies race like never before to develop antiviral treatments and vaccines to curtail the immediate and most severe effects of contracting the virus. However, as new cases and unforeseen symptoms emerge, some scientists are shifting their focus to the extended repercussions of patients who survived their brush with COVID-19....
Read More